Inequalities in sickle cell therapies - Dr Stephen Hibbs, Dr Paul Telfer, Mary-Shaniqua - Patient Advocate
About this episode
The episode discusses health inequalities in sickle cell disease through expert and patient perspectives.
In this extended episode of the HemaSphere podcast, based on a must-read Perspective " Can health inequalities in sickle cell disease be addressed through novel therapies? ", our host Scientific Editor Charles de Bock discusses sickle cell disease with co-authors, covering both expert and lived-patient perspectives. They explore the complexities of living with the disease, the current treatment landscape, and highlight the ongoing health inequalities faced by patients, the impact of withdrawn therapies, and the need for improved communication and trust between patients and healthcare providers. Further information: No One's Listening Report Shaniqua's Sickle Chronicles NICE (National Institute for Health and Care Excellence) UK NHS blood donation Please take a few minutes and let us know what you think about this episode! Podcast Feedback
More episodes of HemaSphere Podcast
- Blinatumomab in De Novo AYA ALL - Dr Matthew Greenwood
- Defining Lineage in Ambiguous Leukemia: A Transcriptomic View - Dr. Anikó Sijs-Szabó & Roger Mulet Lázaro, PhD
- EHA/EBMT Survey on Grading and Management of ICAHT - Dr Kai Rejeski
- Tackling NUP98 Rearranged AML in Pediatric Oncology - Prof Michel Zwaan, Prof Olaf Heidenreich
- Part 2 - Metabolism in hematology - Ep 3.4
- Part 1 - Metabolism in hematology - Ep 3.4
Explore listener stats, chart rankings, contacts and more on the HemaSphere Podcast podcast page.